Hypertension, hypertension-clustering factors and Alzheimer's disease

Neurological Research

Volumn 25, Issue 6, 2003, Pages 675-680

  Skoog, Ingmar ^a   Gustafson, Deborah ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Cerebrovascular disease; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; INSULIN; NITRENDIPINE; STATINE DERIVATIVE;

ALZHEIMER DISEASE; BLOOD PRESSURE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; NEUROPATHOLOGY; OBESITY; ONSET AGE; PATHOGENESIS; REVIEW; RISK FACTOR; STROKE; WHITE MATTER;

ALZHEIMER DISEASE; ARTERIOSCLEROSIS; CEREBROVASCULAR DISORDERS; CLUSTER ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; OBESITY; RISK FACTORS;

EID: 0042888745     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164103101201986     Document Type: Review

References (94)

1. Dannenberg A, Garrison R, Kannel WB. Incidence of hypertension in the Framingham Study. Am J Publ Health 1988; 78: 676-679
2. Kannel WB. Risk stratification in hypertension: New insights from the Framingham Study. Am J Hypertens 2000; 13: 3S-10S
3. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: A global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003; 361: 717-725
4. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-1145
5. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 2000; 21: 49-55
6. Kivipelto M, Helkala E-L, Laakso M, Hänninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. Brit Med J 2001; 322: 1447-1451
7. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Arch Neurol 2003; 60: 223-228
8. Ruitenberg A. Vascular factors in dementia. Observations in the Rotterdam Study. Rotterdam: Erasmus University, 2000
9. Wu C, Zhou D, Wen C, Zhang L, Como P, Qiao Y. Relationship between blood pressure and Alzheimer's disease in Linxian County, China. Life Sci 2003; 72: 1125-1133
10. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002; 58: 1175-1181.
11. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 1995; 45: 1161-1168
12. Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 2001; 58: 1640-1646
13. Qiu C, Winblad B, Viitanen M, Fratiglioni L. Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: A community-based, longitudinal study. Stroke 2003; 34: 594-599
14. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: The Kungsholmen project. Brit Med J 1996; 312: 805-808
15. Skoog I, Andreasson LA, Landahl S, Lernfelt B. A population-based study on blood pressure and brain atrophy in 85-year-olds. Hypertension 1998; 32: 404-409
16. Hogan D, Ebly E, Rockwood K. Weight, blood pressure, osmolarity, and glucose levels across various stages of Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1997; 8: 147-151
17. Ruitenberg A, Skoog I, Ott A, Aevarsson O, Witteman JC, Lernfelt B, et al. Blood Pressure and Risk of Dementia: Results from the Rotterdam Study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 2001; 12: 33-39
18. Guo Z, Viitanen M, Winblad B, Fratiglioni L. Low blood pressure and incidence of dementia in a very old sample: Dependent on initial cognition. J Am Geriatr Soc 1999; 47: 723-726
19. Burke W, Coronado P, Schmitt C, Gillespie K, Chung H. Blood pressure regulation in Alzheimer's disease. J Autonomic Nervous System 1994; 48: 65-71
20. Passant U. Posture and brain function in dementia. A study with special reference to orthostatic hypotension. Thesis. Lund: University of Lund, 1996
21. Chalmers J, Arnolda L, et al. Central nervous control of blood pressure. In: Swales J, ed. Textbook of hypertension, Oxford: Blackwell Scientific Publications, 1994: pp. 409-426
22. Reis D. The brain and hypertension. Arch Neurol 1988; 45: 180-183
23. Lantos P, Cairns N. The neuropathology of Alzheimer's disease. In: Burns A, Levy R, eds. Dementia London: Chapman and Hall, 1994: pp. 185-207
24. Adams J, Brierley J, Connor R, Treip C. The effects of systemic hypotension upon the human brain. Clinical and neuropathological observations in 11 cases. Brain 1966; 89: 235-267
25. Skoog I. A review on blood pressure and ischaemic white matter lesions. Dement Geriatr Cogn Disord 1998; 9 (Suppl. 1): 13-19
26. de la Torre J. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer Disease. Alzheimer Dis Assoc Disord 2000; 14: S72-S81
27. Guo Z, Fratiglioni L, Zhu L, Fastbom J, Winblad B, Viitanen M. Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use. Arch Neurol 1999; 56: 991-996
28. Skoog I, Lernfelt B, Landahl S. High blood pressure and dementia. Lancet 1996; 348: 65-66
29. Guo Z, Fratiglioni L, Viitanen M, Lannfelt L, Basun H, Fastbom J, et al. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: Variation by use of antihypertensive medication? Am J Epidemiol 2001; 153: 225-231
30. Richards SS, Emsley CL, Roberts J, Murray MD, Hall K, Gao S, et al. The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J Am Geriatr Soc 2000; 48: 1035-1041
31. in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: The Rotterdam Study. Neurobiol Aging 2001; 22: 407-412
32. Forette F, Seux M-L, Staessen J, Thijs L, Birkenhäger W, Babarskiene M-R, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (syst-Eur) trial. Lancet 1998; 352: 1347-1351
33. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, et al. The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002; 162: 2046-2052
34. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. Brit Med J 1996; 312: 801-805
35. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. For the SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE). Principal results of a randomised double-blind intervention trial. J Hypertens 2003; 21: 875-886
36. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222
37. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, et al. Risk of dementia after stroke in a hospitalized cohort: Results of a longitudinal study. Neurology 1994; 44: 1885-1891
38. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol 1986; 19: 253-262
39. Skoog I, Palmertz B, Andreasson LA. The prevalence of white-matter lesions on computed tomography of the brain in demented and nondemented 85-year-olds. J Geriatr Psychiatry Neurol 1994; 7: 169-175
40. de Leeuw FF, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, et al. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999; 46: 827-833
41. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002; 125: 765-772
42. Snowdon D, Greiner L, Mortimer J, Riley K, Greiner P, Markesbery W. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 277: 813-817
43. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003; 34: 392-396
44. Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med 1993; 328: 153-158
45. Skoog I. Blood pressure and dementia. In: Hansson L, Birkenhäger W, eds. Handbook of Hypertension. Vol 18. Assessment of hypertensive organ damage, Amsterdam: Elsevier Science BV, 1997: pp. 303-331
46. Skoog I. Risk factors for vascular dementia: A review. Dementia 1994; 5: 137-144
47. Skoog J, Vanmechelen E, Andreasson LA, Palmertz B, Davidsson P, Hesse C, et al. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: Relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration 1995; 4: 433-442
48. Skoog I, Davidsson P, Aevarsson O, Vanderstichele H, Vanmechelen E, Blennow K. Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: A population-based study in 85-year-olds. Dement Geriatr Cogn Disord 2003; 15: 169-176
49. Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karlsson I, et al. A population study on blood-brain barrier function in 85-year-olds: Relation to Alzheimer's disease and vascular dementia. Neurology 1998; 50: 966-971
50. Lim A, Tsuang D, Kukull W, Nochlin D, Leverenz J, McCormick W, et al. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc 1999; 47: 564-569
51. Nagy Z, Esiri M, Jobst K, Morris J, King E, McDonald B, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 165-170
52. Heyman A, Fillenbaum G, Welsh-Bohmer K, Gearing M, Mirra S, Mohs R, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998; 51: 159-162
53. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169-175
54. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999; 174: 45-50
55. White L, Petrovich H, Hardman J, Nelson J, Davis DG, Webster Ross G, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 2002; 977: 9-23
56. Erkinjuntti T, Hachinski V. Dementia post stroke. In: Teasell R, ed. Physical Medicine and Rehabilitation: State of the Art Reviews. Vol 7, Philadelphia: Hanley & Belfus Inc., 1993: pp. 195-212
57. Johansson B. Pathogenesis of vascular dementia: The possible role of hypertension. Dementia 1994; 5: 174-176
58. Shah GN, Mooradian AD. Age-related changes in the blood-brain barrier. Exp Gerontol 1997; 32: 501-519
59. Jendroska K, Poewe W, Daniel S, Pluess J, Iwerssen-Schmidt H, Paulsen J, et al. Ischemic stress induces deposition of amyloid b immunoreactivity in human brain. Acta Neuropathol 1995; 90: 461-466
60. Hall E, Oostveen J, Dunn E, Carter D. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 1995; 135: 17-27
61. Bennett SA, Pappas BA, Stevens WD, Davidson CM, Fortin T, Chen J. Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion. Neurobiol Aging 2000; 21: 207-214
62. Kalaria R, Bhatti S, Palatinsky E, Pennington D, Shelton E, Chan H, et al. Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. NeuroReport 1993; 4: 211-214
63. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: The HAAS. Honolulu-Asia aging Study. Neurobiol Aging 2000; 21: 57-62
64. Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC III. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995; 131: 162-169
65. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002; 137: 149-155
66. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk for Alzheimer's disease. Arch Internal Med 2003; 163: 1524-1528
67. Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev 2002; 1: 61-77
68. Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: The Honolulu-Asia aging study [In Process Citation]. Arterioscler Thromb Vasc Biol 2000; 20: 2255-2260
69. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross sectional population based study. Brit Med J 1997; 315: 1045-1049
70. Notkola I-L, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, apolipoprotein E e4 allele, and Alzheimer's disease. Neuroepidemiology 1998; 17: 14-20
71. Sparks D. Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease? Ann NY Acad Sci 1997; 826: 128-146
72. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 2001; 10: 10
73. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998; 95: 6460-6464
74. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000; 356: 1627-1631
75. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57: 1439-1443
76. Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002; 59: 223-227
77. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study [see comments]. Neurology 1999; 53: 1937-1942
78. Leibson C, Rocca W, Hanson V, Cha R, Kokmen E, O'Brien P, et al. Risk of dementia among persons with diabetes mellitus: A population-based cohort study. Am J Epidemiol 1997; 145: 301-308
79. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002; 51: 1256-1262
80. Mooradian AD. Pathophysiology of central nervous system complications in diabetes mellitus. Clin Neurosci 1997; 4: 322-326
81. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: A review. Diabetologia 2001; 44: 129-146
82. Yan S, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. RAGE and amyloid-b peptide neurotoxicity in Alzheimer's disease. Nature 1996; 382: 685-691
83. Lethem R, Orrell M. Antioxidants and dementia. Lancet 1997; 349: 1189-1190
84. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462
85. Hamet P, Richard L, Dam T-V, Teiger E, Orlov S, Gaboury L, et al. Apoptosis in target organs of hypertension. Hypertension 1995; 26: 642-648
86. Wright J, Harding J. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev 1994; 18: 21-53
87. Ekeberg O, Kjeldsen S, Eide I, Leren P. Childhood traumas and psychosocial characteristics of 50-year-old men with essential hypertension. J Psychosom Res 1990; 34: 643-649
88. Persson G, Skoog I. A prospective population study of psychosocial risk factors for late-onset dementia. Int J Geriatric Psychiatry 1996; 11: 15-22
89. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. b-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996; 380: 168-171
90. Luscher T. Local relaxant and constricting factors in the vessel wall. In: Swales J, ed. Textbook of Hypertension, Oxford: Blackwell Scientific Publications, 1994
91. Umans J. Less nitric oxide, more pressure, or the converse? Lancet 1997; 349: 816
92. Arendash G, Su G, Crawford F, Bjugstad K, Mullan M. Intravascular beta-amyloid infusion increases blood pressure: Implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's disease. Neurosci Lett 1999; 268: 17-20
93. Skoog I. The interaction between vascular disorders and Alzheimer's disease. In: Iqbal K, Swaab D, Winblad B, Wisniewski H, eds. Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics, Chichester: John Wiley & Sons Ltd, 1999: pp. 523-530
94. Skoog I. Possibilities for secondary prevention of Alzheimer's disease. In: Mayeux R, Christen Y, eds. The Epidemiology of Alzheimer's Disease: From Gene to Prevention, Berlin: Springer Verlag, 1999: pp. 121-134